logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Satoshi Tamada

bell-land general hospital
H指数:26
被引数:6,730

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis Assessed by Modified MD Anderson Criteria: An Open-Label Phase 2 Study

卡博替尼在伴有骨转移的晚期肾细胞癌患者中的疗效评估：一项基于改良MD Anderson标准的开放标签II期研究

INTERNATIONAL JOURNAL OF UROLOGY
IF2.2
2026-05-250
OA
Hongo, Fumiya; Nakai, Yasutomo; Nozawa, Masahiro; Kato, Taigo; Kamikawa, Sadanori; Tamada, Satoshi; Yamada, Kaori; Soeda, Junpei; Tsubouchi, Ryoichi; Osaka, Tsuyoshi; Uemura, Hirotsugu
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial

帕博利珠单抗联合阿昔替尼对比舒尼替尼治疗晚期透明细胞肾细胞癌：KEYNOTE-426 III期试验的5年生存率和生物标志物分析

Nature Medicine
IF50
2025-08-010
OA
Brian I. Rini; Elizabeth R. Plimack; Viktor Stus; Rustem Gafanov; Tom Waddell; Dmitry Nosov; Frédéric Pouliot; Boris Alekseev; Denis Soulières; Bohuslav Melichar; Ihor Vynnychenko; Sergio Jobim de Azevedo; Delphine Borchiellini; Raymond S. McDermott; Jens Bedke; Satoshi Tamada; Sterling Wu; Julia Markensohn; Yiwei Zhang; Andrey Loboda; Amir Vajdi; Rodolfo F. Perini; Joseph Burgents; Thomas Powles
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study[Eur Urol 84(5) (2023) 449-454]
EUROPEAN UROLOGY
IF25.2
2023-12-010
OA
Plimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Pouliot, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; McDermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Molife, L. Rhoda; Li, Chenxiang; Perini, Rodolfo; Bedke, Jens; Rini, Brian I.
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study ( vol 84 , pg , 449 , 2023)
EUROPEAN UROLOGY
IF25.2
2023-11-010
OA
Plimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Poulioti, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; McDermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Li, Chenxiang; Perini, Rodolfo; Molife, L. Rhoda; Bedke, Jens; Riniu, Brian I.
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
EUROPEAN UROLOGY
IF25.2
2023-11-0130
PRE
Plimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Pouliot, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; Mcdermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Li, Chenxiang; Perini, Rodolfo; Molife, L. Rhoda; Bedke, Jens; Rini, Brian I.
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma
EUROPEAN UROLOGY
IF25.2
2022-10-0120
PRE
Bedke, Jens; Rini, Brian, I; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Waddell, Tom; Nosov, Dimitry; Pouliot, Frederic; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Azevedo, Sergio J.; Borchiellini, Delphine; McDermott, Raymond S.; Tamada, Satoshi; Nguyen, Allison Martin; Wan, Shuyan; Perini, Rodolfo F.; Molife, L. Rhoda; Atkins, Michael B.; Powles, Thomas
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)

比卡鲁胺联合雄激素阻断治疗去势抵抗性前列腺癌的恩扎鲁胺与氟他胺: 多中心随机II期试验的研究方案 (ocuu-crpc研究)

BMC CANCER
IF3.4
2019-04-1115
OAAI
Iguchi, Taro; Tamada, Satoshi; Kato, Minoru; Yasuda, Sayaka; Yamasaki, Takeshi; Nakatani, Tatsuya
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

帕博利珠单抗联合阿西替尼与舒尼替尼治疗晚期肾细胞癌的比较

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2019-03-212.4K
OAAI
Rini, Brian I.; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Hawkins, Robert; Nosov, Dmitry; Pouliot, Frederic; Alekseev, Boris; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Kryzhanivska, Anna; Bondarenko, Igor; Azevedo, Sergio J.; Borchiellini, Delphine; Szczylik, Cezary; Markus, Maurice; McDermott, Raymond S.; Bedke, Jens; Tartas, Sophie; Chang, Yen-Hwa; Tamada, Satoshi; Shou, Qiong; Perini, Rodolfo F.; Chen, Mei; Atkins, Michael B.; Powles, Thomas
PROSPECTIVE RANDOMIZED TRIAL OF ALPHA-BLOCKER COMBINED WITH IMIDAFENACIN IN THE TREATMENT OF NOCTURIA IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CONCOMITANT OVERACTIVE BLADDER SYNDROME: RESULTS OF GOOD-NIGHT STUDY
JOURNAL OF UROLOGY
IF6.8
2012-04-011
PREAI
Inamoto, Teruo; Tsujimura, Akira; Nonomura, Norio; Azuma, Hauhito; Akino, Hironobu; Oguchi, Naoki; Kitagawa, Yasuhide; Segawa, Naoki; Tamada, Satoshi; Shimizu, Nobutaka; Watanabe, Akihiko; Urashima, Mitsuyoshi; Okuyama, Akihiko; Katsuoka, Yoji; Uemura, Hirotsugu; Nakatani, Tatsuya; Namiki, Mikio; Fuse, Hideki; Matsuda, Tadashi; Osamu, Yokoyama

研究方向

暂未获取到该数据
T
Tatsuya Nakatani
H 指数:51论文数:818被引数:1.2万
T
Taro Iguchi
H 指数:21论文数:127被引数:2,536
B
Brian I. Rini
H 指数:122论文数:1,339被引数:7.7万
R
Rodolfo F. Perini
H 指数:36论文数:234被引数:1.5万
E
Elizabeth R. Plimack
H 指数:79论文数:766被引数:4.8万
V
V.P. Stus
H 指数:19论文数:81被引数:6,816
I
Ihor Vynnychenko
H 指数:32论文数:97被引数:2.1万
R
Rustem Gafanov
H 指数:24论文数:97被引数:7,138
J
Jens Bedke
H 指数:56论文数:606被引数:2.7万
B
Bohuslav Melichar
H 指数:73论文数:796被引数:4.4万